Smith & Nephew PLC
SNN
Company Profile
Business description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact
Hatters Lane
Building 5, Croxley Park
WatfordHertfordshireWD18 8YE
GBRT: +44 1923477100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
17,349
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,775.00 | 4.40 | 0.05% |
CAC 40 | 7,745.41 | 60.73 | 0.79% |
DAX 40 | 23,708.93 | 192.70 | 0.82% |
Dow JONES (US) | 42,628.83 | 431.04 | 1.02% |
FTSE 100 | 8,885.54 | 34.91 | 0.39% |
HKSE | 24,060.99 | 168.43 | 0.70% |
NASDAQ | 19,730.93 | 324.11 | 1.67% |
Nikkei 225 | 38,311.33 | 477.08 | 1.26% |
NZX 50 Index | 12,690.13 | 137.26 | 1.09% |
S&P 500 | 6,046.58 | 69.61 | 1.16% |
S&P/ASX 200 | 8,548.40 | 1.00 | 0.01% |
SSE Composite Index | 3,388.73 | 11.73 | 0.35% |